Testing effectiveness (Phase 2)Study completedNCT02016755
What this trial is testing
A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia
Who this might be right for
Critical Limb IschemiaVascular DiseasesPeripheral Arterial Disease
AnGes USA, Inc. 10